ENDODERMA

IP & RECOGNITION

HOME > ENDODERMA > IP & RECOGNITION

Endoderma, with competitive stand alone and collaboratory R&D capabilities, will be a global leading company in TDDS and future technologies covering electroceuticals and DBO platform of microneedle manufaturing.

No	Patent No.	Title of Patent Granted	Nation
1	10-1831948 10-1831949	Microstructure Using Cross-linked Hyaluronic Acid Hydrogel and Process For Preparing the Same	(6)
2	10-1838715	Composition For Manufacturing Microneedle Comprising CrosslinkedHyaluronic Acid and Non-crosslinked Hyaluronic Acid
3	10-1973801	Hyaluronic Acid Microstructure Having Excellent Dissolving Properties	(38)
4	10-2064503	Microstructure For Transdermal Absorption and Process for Preparing the Same	(38)

RECOGNITION

Functional Cosmetics (Approval by KFDA)
eve VEGAN
Sanitary Approval from Chinese Authority

ENDODERMA Factory

Cerificate of Cosmetic Good Manufacturing Practice

CGMP
ISO22716

AWARDS

2016 Awarded with Gold Medal Prize in the International Exhibition of Inventions Geneve
2016 Awarded with Special Award Prize in the International Exhibition of Inventions Geneve
(Association of Polish Inventions and Rationalizers)

2016 Awarded with Gold Medal / Special Award in the International Exhibition of Inventions Geneve

Endoderma's genuine microstructure was awarded with Gold Medal and Special Award (by Special Award of Association of Polish Inventions and Rationalizers) in the International Exhibition of Inventions Geneve

Intemational Exhibition of Inventions Geneve,Switzerland is the largest invention fair which takes place annually.
Endoderma's genuine microstructure uses cross-linked hyaluronic acid and is made into bio-degradable microstructure to create continuity, moisture improvement effect and wrinkle reduction effect on the skin of the body that last up to seven days.
Endoderma was awarded with Gold Medal and Special Award by gaining recognition for technology, feasibility and marketability in the International Exhibition of Inventions Geneve.